<bill session="109" type="h" number="5887" updated="2023-01-12T17:52:35Z">
  <state datetime="2006-07-25">REFERRED</state>
  <status>
    <introduced datetime="2006-07-25"/>
  </status>
  <introduced datetime="2006-07-25"/>
  <titles>
    <title type="display">Vaccine Safety and Public Confidence Assurance Act of 2006</title>
    <title type="official" as="introduced">To improve vaccine safety research, and for other purposes.</title>
    <title type="short" as="introduced">Vaccine Safety and Public Confidence Assurance Act of 2006</title>
  </titles>
  <sponsor bioguide_id="W000267"/>
  <cosponsors>
    <cosponsor bioguide_id="B001149" joined="2006-07-26"/>
    <cosponsor bioguide_id="K000113" joined="2006-11-13"/>
    <cosponsor bioguide_id="M000087" joined="2006-07-25"/>
    <cosponsor bioguide_id="M001147" joined="2006-09-14"/>
    <cosponsor bioguide_id="M000627" joined="2006-07-26"/>
    <cosponsor bioguide_id="S000522" joined="2006-09-12"/>
  </cosponsors>
  <actions>
    <action datetime="2006-07-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2006-07-25" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2006-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Centers for Disease Control and Prevention (CDC)"/>
    <term name="Civil Rights and Liberties, Minority Issues"/>
    <term name="Clinical trials"/>
    <term name="Communication in medicine"/>
    <term name="Communication in science"/>
    <term name="Conflict of interests"/>
    <term name="Congressional reporting requirements"/>
    <term name="Data banks"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Economics and Public Finance"/>
    <term name="Executive reorganization"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to research"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Health information systems"/>
    <term name="Health surveys"/>
    <term name="Medical records"/>
    <term name="Peer review organizations (Medicine)"/>
    <term name="Pharmaceutical research"/>
    <term name="Research and development"/>
    <term name="Research grants"/>
    <term name="Right of privacy"/>
    <term name="Science, Technology, Communications"/>
    <term name="Toxicology"/>
    <term name="Vaccination"/>
    <term name="Vaccines"/>
  </subjects>
  <amendments/>
  <summary date="2006-09-25T19:16:45Z" status="Introduced in House">Vaccine Safety and Public Confidence Assurance Act of 2006 - Amends the Public Health Service Act to establish the Agency for Vaccine Safety Evaluation in the Office of the Secretary of Health and Human Services. Requires the Director for Vaccine Safety Evaluation to: (1) conduct or support safety research and monitor licensed vaccines; (2) develop a vaccine safety research agenda; (3) evaluate means to promote compliance with federal adverse reaction reporting requirements; (4) provide a clearinghouse for vaccine studies; (5) ensure that functions relating to vaccine monitoring or research on adverse reactions are not carried out by anyone with a conflict of interest; (6) oversee the Vaccine Safety Datalink Project; and (7) resolve U.S. conflicts of interest related to international agreements, partnerships, and activities.

Allows the Director to establish a program of awarding fellowships for research on vaccine safety.

Requires the Commissioner of Food and Drugs to provide the Director, upon request, with complete access to all vaccine-related information submitted to the Food and Drug Administration (FDA) by vaccine manufacturers.

Requires the Director to require vaccine manufacturers to: (1) provide for postmarketing surveillance and clinical testing for any acute or chronic adverse reactions associated with the vaccine; and (2) register in a qualified public registry each clinical trial conducted or supported by the manufacturer with respect to the vaccine.

Transfers to the Agency Centers for Disease Control and Prevention (CDC) responsibilities for the Vaccine Safety Datalink Project, the Clinical Immunization Safety Assessment Centers, or any other post-licensure vaccine safety monitoring activities.

Requires the Secretary to establish an advisory council in the Agency.</summary>
</bill>
